← All trials
NCT05675813
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 15, 2023
- Primary completion
- Dec 15, 2024
- Completion date
- Dec 15, 2026
- First posted
- Jan 9, 2023
- Last posted
- Jan 9, 2023
- Enrollment
- 264
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Jiao Tong UniversityLead sponsor
- Huazhong University of Science and TechnologyCollaborator
- Sichuan UniversityCollaborator
- Peking UniversityCollaborator
- Jiao Tong UniversityReponsible party - principal investigator
- Southern Medical UniversityCollaborator
- Sun Yat-Sen UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.